Brandy Davis
Family · Griffin, GANPI 1871018937
Payments from drug & device makers
Across 60 payments — averaging $17.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$320
- Lilly USA, LLC$104
- Biohaven Pharmaceutical Holding Company Ltd.$84
- Boston Scientific$81
- Biohaven Pharmaceuticals, Inc.$78
- Regeneron Healthcare Solutions, Inc.$72
- plus $326 from 16 others
What the payments were for
- Food & beverage$1,066100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $320 |
| Lilly USA, LLC | 6 | $104 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $84 |
| Boston Scientific | 4 | $81 |
| Biohaven Pharmaceuticals, Inc. | 3 | $78 |
| Regeneron Healthcare Solutions, Inc. | 2 | $72 |
| Corcept Therapeutics | 2 | $38 |
| Novo Nordisk | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Sanofi | 1 | $26 |
| Amarin Pharma, Inc. | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Pfizer | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $20 |
| Johnson & Johnson | 1 | $16 |
| Novartis | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Amgen | 1 | $14 |
| Cranial Technologies, Inc | 1 | $14 |
| Gilead | 1 | $14 |
| Bayer | 1 | $13 |
| AstraZeneca | 1 | $12 |
How this compares
$1,066 in reported general payments places this provider in the 65th percentile of 6,258 family providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 43 | $3,489 |
| Famotidine | 203 | $2,776 |
| Dicyclomine Hcl | 68 | $2,423 |
| Pantoprazole Sodium | 118 | $882 |
| Lactulose | 29 | $574 |
| Omeprazole | 36 | $465 |
| Ondansetron Hcl | 23 | $318 |
| Doxycycline Hyclate | 12 | $208 |
| Metronidazole | 19 | $175 |
| Spironolactone | 11 | $116 |
| Propranolol Hcl | 13 | $112 |
| Metoclopramide Hcl | 11 | $108 |
| Amitriptyline Hcl | 14 | $104 |
Paid to pharmacies, not to this prescriber.
Other family in Griffin
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.